Sensing of antipyretic carboxylates by simple chromogenic calix[4]pyrroles

Journal of the American Chemical Society

Volumn 127, Issue 23, 2005, Pages 8270-8271

  Nishiyabu, Ryuhei ^a   Anzenbacher Jr , Pavel ^a  

^a BOWLING GREEN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANION; CALIX[4]PYRROLE; CARBOXYLIC ACID; CHROMOGENIC SUBSTRATE; ELECTROLYTE; HYDROGEN; MACROCYCLIC COMPOUND; OCTAMETHYLCALIX[4]PYRROLE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ABSORPTION SPECTROSCOPY; ANTIPYRETIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CHEMICAL STRUCTURE; CHROMATOPHORE; COLOR; ELECTRON; ELECTRON TRANSPORT; HYDROGEN BOND; SENSOR; SIGNAL TRANSDUCTION; SYNTHESIS; TITRIMETRY;

ANALGESICS, NON-NARCOTIC; ANIMALS; ANIONS; BIOSENSING TECHNIQUES; BLOOD PROTEINS; CALIXARENES; CARBOXYLIC ACIDS; HUMANS; IBUPROFEN; NAPROXEN; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PORPHYRINS; SALICYLATES; SERUM ALBUMIN, BOVINE; SPECTROPHOTOMETRY;

EID: 20444449667     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja051421p     Document Type: Article

References (22)

1. (a) Marshall, W. J.; Bangert, S. K. Clinical Chemistry, 5th ed.; Elsevier: Edinburg, 2004.
2. (b) Schmidt, R. F.; Thews, G. Human Physiology, 2nd ed.; Springer-Verlag: Berlin, 1989.
3. (c) Ullmann's Encyclopedia of Industrial Chemistry, 6th ed.; Wiley VCH: New York, 1999.
4. (a) Martínez-Máñez R.; Sancenón, F. Chem. Rev. 2003, 103, 4419-4476.
5. (b) Suksai, C.; Tuntulani, T. Chem. Soc. Rev. 2003, 32, 192-202.
6. (c) Beer, P. D.; Gale, P. A. Angew. Chem., Int. Ed. 2001, 40, 486-516.
7. (a) Baeyer, A. Ber. Dtsch. Chem. Ges. 1886, 19, 2184-2185.
8. (b) Gale, P. A.; Sessler, J. L.; Král, V. Chem. Commun. 1998, 1-8.
9. (c) Gale, P. A.; Anzenbacher, P., Jr.; Sessler, J. L. Coord. Chem. Rev. 2001, 222, 57-102.
10. (a) Miyaji, H.; Sato, W.; Sessler, J. L. Angew. Chem., Int. Ed. 2000, 39, 1777-1780.
11. (b) Anzenbacher, P., Jr.; Jursíková, K.; Sessler, J. L. J. Am. Chem. Soc. 2000, 122, 9350-9351.
12. (a) Beer, P. D.; Sikanyia, H. Polyhedron 1990, 9, 1747-1749.
13. (b) Ward, C. J.; Patel, P.; James, T. D. Org. Lett. 2002, 4, 477-479.
14. (c) Jiménez, D.; Martínez-Máñez, R.; Sancenón, F.; Soto, J. Tetrahedron Lett. 2004, 45, 1257-1259.
15. Anzenbacher, P., Jr.; Jursíková, K.; Shriver, J. A.; Miyaji, H.; Lynch, V. M.; Sessler, J. L.; Gale, P. A. J. Org. Chem. 2000, 65, 7641-7645.
16. 2O). The degree of hydration was estimated from elemental analyses. The fits are shown in Supporting Information.
17. Titration experiments and Job plot indicated that the pyrophosphate-sensor stoichiometry was 2:1 due to pyrophosphate dimerization: Chu, F.; Flatt, L. S.; Anslyn, E. V. J. Am. Chem. Soc. 1994, 116, 4194-4204.
18. Gale, P. A.; Navakhun, K.; Camiolo, S.; Light, M. E.; Hursthouse, M. B. J. Am. Chem. Soc. 2002, 124, 11228-11229.
19. 1H NMR spectrum.
20. -1, respectively.
21. For more details, see Supporting Information.
22. The upper therapeutic concentrations of antipyretic carboxylates, such as salicylate, are ∼2.5-3.0 mM in plasma. Clinical overdoses requiring treatment are in the excess of 4.0-5.1 mM in adults; see ref 1a, pp 343-345.